Original document(50 pages)  中文版
    Phenoxyphenyl and phenoxybenzyl oxazolidine-2,4-diones and thiazolidine-2,4-diones of formula (I) are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.
Application Number
申请号		 200580002716 Application Date
申请日		 2005.01.18
Title 名称 Antidiabetic oxazolidinediones and thiazolidinediones
Publication Number
公开号		 1910163 Publication Date
公开日		 2007.02.07
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D263/44;C07D277/34;A61K31/421;A61K31/426;A61P3/10
Applicant(s) Name
申请人		 Merck & Co. Inc.
Address 地址
Inventor(s) Name 发明人 Shi Guo Q.;Meinke Peter T.;Dropinski James F.;Zhang Yong
Attorney & Agent 代理人 guan lixin li liantao
More information 更  多  信  息


 Related patents information
2-substituted oxylacetic acid derivant, preparation trifluoromethyl and its appliance
Compounds for the treatment of dyslipidemia and other lipid disorders
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.